Bidirectional modulation of GABAergic transmission by cholecystokinin in hippocampal dentate gyrus granule cells of juvenile rats

Journal of Physiology

Volumn 572, Issue 2, 2006, Pages 425-442

  Deng, Pan Yue ^a   Lei, Saobo ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; CALCIUM ION; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; POTASSIUM ION; PROTEIN KINASE C; 4 AMINOBUTYRIC ACID; CHARYBDOTOXIN; CHOLECYSTOKININ A RECEPTOR; G PROTEIN COUPLED RECEPTOR; PAXILLINE; POTASSIUM CHANNEL;

4 AMINOBUTYRIC ACID RELEASE; ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN REGION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL ACTIVITY; CONTROLLED STUDY; DENTATE GYRUS; ENZYME ACTIVITY; GABAERGIC TRANSMISSION; GENE ACTIVATION; GRANULE CELL; HIPPOCAMPUS; INTERNEURON; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION; ANIMAL MODEL; CARBOXY TERMINAL SEQUENCE; ENTORHINAL CORTEX; HYPERPOLARIZATION; NEUROMODULATION; PATCH CLAMP TECHNIQUE; POTASSIUM CURRENT; PROTEIN INTERACTION; SUBICULUM; SYNAPTIC TRANSMISSION;

ACTION POTENTIALS; ANIMALS; ANIMALS, NEWBORN; CALCIUM; CHARYBDOTOXIN; CHOLECYSTOKININ; DENTATE GYRUS; EVOKED POTENTIALS; GAMMA-AMINOBUTYRIC ACID; GTP-BINDING PROTEINS; INDOLES; INTERNEURONS; NEUROTOXINS; PATCH-CLAMP TECHNIQUES; PHOSPHOLIPASE C; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, GABA-A; SYNAPTIC TRANSMISSION; VOLITION;

EID: 33645512601     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2005.104463     Document Type: Article

References (71)

1. 2 by bromoenol lactone and trifluoromethyl ketones. J Biol Chem 270, 445-450.
2. Beinfeld MC (1983). Cholecystokinin in the central nervous system: A minireview. Neuropeptides 3, 411-427.
3. Beinfeld MC, Meyer DK, Eskay RL, Jensen RT & Brownstein MJ (1981). The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay. Brain Res 212, 51-57.
4. Branchereau P, Champagnat J & Denavit-Saubie M (1993). Cholecystokinin-gated currents in neurons of the rat solitary complex in vitro. J Neurophysiol 70, 2584-2595.
5. Brenner R, Chen QH, Vilaythong A, Toney GM, Noebels JL & Aldrich RW (2005). BK channel β4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures. Nat Neurosci 8, 1752-1759.
6. Breukel AI, Lopes da Silva FH & Ghijsen WE (1997). Cholecystokinin (CCK-8) modulates vesicular release of excitatory amino acids in rat hippocampal nerve endings. Neurosci Lett 234, 67-70.
7. Chakfe Y & Bourque CW (2000). Excitatory peptides and osmotic pressure modulate mechanosensitive cation channels in concert. Nat Neurosci 3, 572-579.
8. Chakfe Y & Bourque CW (2001). Peptidergic excitation of supraoptic nucleus neurons: Involvement of stretch-inactivated cation channels. Exp Neurol 171, 210-218.
9. Chen H, Kurenny DE & Smith PA (1993). Heparin prevents M-current over-recovery but not M-current suppression in bullfrog sympathetic ganglion neurones. Brain Res 625, 323-327.
10. Cloues RK & Sather WA (2003). Afterhyperpolarization regulates firing rate in neurons of the suprachiasmatic nucleus. J Neurosci 23, 1593-1604.
11. + conductance. J Neurophysiol 74, 990-1000.
12. Crawley JN & Corwin RL (1994). Biological actions of cholecystokinin. Peptides 15, 731-755.
13. Deschodt-Lanckman M, Bui ND, Noyer M & Christophe J (1981). Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: A study by high pressure liquid chromatography. Regul Pept 2, 15-30.
14. de Tullio P, Delarge J & Pirotte B (1999). Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists). Curr Med Chem 6, 433-455.
15. Ferraro L, Beani L, Trist D, Reggiani A & Bianchi C (1999). Effects of cholecystokinin peptides and GV 150013, a selective cholecystokinin B receptor antagonist, on electrically evoked endogenous GABA release from rat cortical slices. J Neurochem 73, 1973-1981.
16. Goldberg JA & Wilson CJ (2005). Control of spontaneous firing patterns by the selective coupling of calcium currents to calcium-activated potassium currents in striatal cholinergic interneurons. J Neurosci 25, 10230-10238.
17. Greenwood RS, Godar SE, Reaves TA Jr & Hayward JN (1981). Cholecystokinin in hippocampal pathways. J Comp Neurol 203, 335-350.
18. Hendry SH & Jones EG (1985). Morphology of synapses formed by cholecystokinin-immunoreactive axon terminals in region superior of rat hippocampus. Neuroscience 16, 57-68.
19. 3H]GABA from rat cortical slices and cultured mouse cortical neurones. Neurochem Int 30, 171-179.
20. Hill DR, Campbell NJ, Shaw TM & Woodruff GN (1987). Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists. J Neurosci 7, 2967-2976.
21. 3H-MK-329. J Neurosci 10, 1070-1081.
22. Innis RB, Correa FM, Uhl GR, Schneider B & Snyder SH (1979). Cholecystokinin octapeptide-like immunoreactivity: Histochemical localization in rat brain. Proc Natl Acad Sci U S A 76, 521-525.
23. Jagerschmidt A, Guillaume N, Goudreau N, Maigret B & Roques BP (1995). Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction. Mol Pharmacol 48, 783-789.
24. Jassar BS, Harris KH, Ostashewski PM & Jhamandas JH (1999). Ionic mechanisms of action of neurotensin in acutely dissociated neurons from the diagonal band of Broca of the rat. J Neurophysiol 81, 234-246.
25. Kohler C & Chan-Palay V (1988). Cholecystokinin-octapeptide (CCK-8) receptors in the hippocampal region: A comparative in vitro autoradiographic study in the rat, monkey and the postmortem human brain. Neurosci Lett 90, 51-56.
26. Kritzer MF, Innis RB & Goldman-Rakic PS (1988). Regional distribution of cholecystokinin receptors in macaque medial temporal lobe determined by in vitro receptor autoradiography. J Comp Neurol 276, 219-230.
27. Kurennyi DE, Chen H & Smith PA (1997). Low concentrations of muscarine potentiate M-current in bullfrog sympathetic B-neurones. J Auton Nerv Syst 67, 89-96.
28. Lanza M & Makovec F (2000). Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK B receptors located on glutamatergic interneurons. Naunyn Schmiedebergs Arch Pharmacol 361, 33-38.
29. Lei S & McBain CJ (2003). GABA B receptor modulation of excitatory and inhibitory synaptic transmission onto rat CA3 hippocampal interneurons. J Physiol 546, 439-453.
30. Lei S, Orser BA, Thatcher GR, Reynolds JN & MacDonald JF (2001). Positive allosteric modulators of AMPA receptors reduce proton-induced receptor desensitization in rat hippocampal neurons. J Neurophysiol 85, 2030-2038.
31. Madison DV & Nicoll RA (1982). Noradrenaline blocks accommodation of pyramidal cell discharge in the hippocampus. Nature 299, 636-638.
32. 2+. Neuron 6, 533-545.
33. Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, Jaxa-Chamiec A et al. (1990). SKF 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J 271, 515-522.
34. Migaud M, Roques BP & Durieux C (1994). Effects of cholecystokinin octapeptide and BC 264, a potent and selective CCK-B agonist on aspartate and glutamate release from rat hippocampal slices. Neuropharmacology 33, 737-743.
35. + conductance in hippocampal interneurons. J Neurosci 17, 4994 -5003.
36. Moran TH, Robinson PH, Goldrich MS & McHugh PR (1986). Two brain cholecystokinin receptors: Implications for behavioral actions. Brain Res 362, 175-179.
37. Mutt V & Jorpes JE (1968). Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin. Eur J Biochem 6, 156-162.
38. Nishida A, Miyata K, Tsutsumi R, Yuki H, Akuzawa S et al. (1994). Pharmacological profile of
39. Noble F & Roques BP (1999). CCK-B receptor: Chemistry, molecular biology, biochemistry and pharmacology. Prog Neurobiol 58, 349-379.
40. Nunzi MG, Gorio A, Milan F, Freund TF, Somogyi P & Smith AD (1985). Cholecystokinin-immunoreactive cells form symmetrical synaptic contacts with pyramidal and nonpyramidal neurons in the hippocampus. J Comp Neurol 237, 485-505.
41. Ogawa WN, Baptista V, Aguiar JF & Varanda WA (2005). Neurotensin modulates synaptic transmission in the nucleus of the solitary tract of the rat. Neuroscience 130, 309-315.
42. + current I AHP via cyclic AMP-dependent protein kinase in hippocampal neurons. J Neurophysiol 74, 2749-2753.
43. 3H] gamma-aminobutyric acid release in slices from various brain areas. Eur J Pharmacol 250, 423-430.
44. + currents in NG 108-15 cells by substance P and related tachykinins. Br J Pharmacol 119, 315-320.
45. Pommier B, Da Nascimento S, Dumont S, Bellier B, Million E, Garbay C et al. (1999). The cholecystokinin B receptor is coupled to two effector pathways through pertussis toxin-sensitive and -insensitive G proteins. J Neurochem 73, 281-288.
46. Pommier B, Marie-Claire C, Da Nascimento S, Wang HL, Roques BP & Noble F (2003). Further evidence that the CCK2 receptor is coupled to two transduction pathways using site-directed mutagenesis. J Neurochem 85, 454-461.
47. Raffaelli G, Saviane C, Mohajerani MH, Pedarzani P & Cherubini E (2004). BK potassium channels control transmitter release at CA3-CA3 synapses in the rat hippocampus. J Physiol 557, 147-157.
48. Rehfeld JF (1978). Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. J Biol Chem 253, 4022-4030.
49. Rehfeld JF, Hansen HF, Marley PD & Stengaard-Pedersen K (1985). Molecular forms of cholecystokinin in the brain and the relationship to neuronal gastrins. Ann N Y Acad Sci 448, 11-23.
50. Rezayat M, Roohbakhsh A, Zarrindast MR, Massoudi R & Djahanguiri B (2005). Cholecystokinin and GABA interaction in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety. Physiol Behav 84, 775-782.
51. Ruth RE, Collier TJ & Routtenberg A (1982). Topography between the entorhinal cortex and the dentate septotemporal axis in rats. I. Medial and intermediate entorhinal projecting cells. J Comp Neurol 209, 69-78.
52. Ruth RE, Collier TJ & Routtenberg A (1988). Topographical relationship between the entorhinal cortex and the septotemporal axis of the dentate gyrus in rats. II. Cells projecting from lateral entorhinal subdivisions. J Comp Neurol 270, 506-516.
53. Sebret A, Lena I, Crete D, Matsui T, Roques BP & Dauge V (1999). Rat hippocampal neurons are critically involved in physiological improvement of memory processes induced by cholecystokinin-B receptor stimulation. J Neurosci 19, 7230-7237.
54. Shigeyoshi Y, Okamura H, Inatomi T, Matsui T, Ito M, Kaji H et al. (1994). Distribution of mRNA for CCK-B receptor in the brain of Mastomys natalensis: Abundant expression in telencephalic neurons. Brain Res 640, 81-92.
55. Shinohara S & Kawasaki K (1994). Desensitization of cholecystokinin B receptors in GH 3 cells. J Neurochem 62, 1352-1356.
56. Shinohara S & Kawasaki K (1997). Electrophysiological changes in rat hippocampal pyramidal neurons produced by cholecystokinin octapeptide. Neuroscience 78, 1005-1016.
57. Siniscalchi A, Rodi D, Cavallini S, Marino S, Ferraro L et al. (2003). Effects of cholecystokinin tetrapeptide (CCK 4) and of anxiolytic drugs on GABA outflow from the cerebral cortex of freely moving rats. Neurochem Int 42, 87-92.
58. Somogyi P, Hodgson AJ, Smith AD, Nunzi MG, Gorio A & Wu JY (1984). Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin-immunoreactive material. J Neurosci 4, 2590-2603.
59. Steward O & Scoville SA (1976). Cells of origin of entorhinal cortical afferents to the hippocampus and fascia dentata of the rat. J Comp Neurol 169, 347-370.
60. Storm JF (1987). Action potential repolarization and a fast after-hyperpolarization in rat hippocampal pyramidal cells. J Physiol 385, 733-759.
61. Tokimasa T, Simmons MA, Schneider CR & Akasu T (1996). Hyperpolarizing shift of the M-current activation curve after washout of muscarine in bullfrog sympathetic neurons. Neurosci Lett 207, 97-100.
62. Tsujino N, Yamanaka A, Ichiki K, Muraki Y, Kilduff TS, Yagami K et al. (2005). Cholecystokinin activates orexin/hypocretin neurons through the cholecystokinin A receptor. J Neurosci 25, 7459-7469.
63. 3H] cholecystokinin 8 as radioligand. J Neurosci 4, 1021-1033.
64. Walsh KB, Wilson SP, Long KJ & Lemon SC (1996). Stimulatory regulation of the large-conductance, calcium-activated potassium channel by G proteins in bovine adrenal chromaffin cells. Mol Pharmacol 49, 379-386.
65. Wang B & Sims SM (1998). CCK regulates nonselective cation channels in guinea pig gastric smooth muscle cells. Am J Physiol 274, G709-G717.
66. Wank SA (1995). Cholecystokinin receptors. Am J Physiol 269, G628-G646.
67. Wu T & Wang HL (1996 a). The excitatory effect of cholecystokinin on rat neostriatal neurons: Ionic and molecular mechanisms. Eur J Pharmacol 307, 125-132.
68. q/11 mediates cholecystokinin activation of the cationic conductance in rat substantia nigra dopaminergic neurons. J Neurochem 66, 1060-1066.
69. You ZB, Godukhin O, Goiny M, Nylander I, Ungerstedt U, Terenius L et al. (1997). Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes. Naunyn Schmiedebergs Arch Pharmacol 355, 576-581.
70. You ZB, Herrera-Marschitz M, Brodin E, Meana JJ, Morino P, Hokfelt T et al. (1994). On the origin of striatal cholecystokinin release: Studies with in vivo microdialysis. J Neurochem 62, 76-85.
71. You ZB, Herrera-Marschitz M, Pettersson E, Nylander I, Goiny M, Shou HZ et al. (1996). Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: Regional and receptor specificity. Neuroscience 74, 793-804.